Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04462081 · ClinicalTrials.gov registry record
Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 100
- Enrollment target
NCT04462081: Completed study, sponsored by University of California, San Diego.
NCT04462081 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04462081 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
To assess the feasibility in diabetics in a primary care setting of screening for NAFLD and advanced fibrosis, by using non-invasive magnetic resonance imaging (MRI) to estimate the hepatic proton density fat fraction (MRI-PDFF) and magnetic resonance elastography (MRE) to estimate hepatic stiffness.
Primary Outcome
Evaluation of liver fat fraction and liver stiffness, as determined by magnetic resonance imaging, are associated with subclinical cardiovascular disease, as evaluated by coronary artery calcium scan in diabetics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
What the finished NCT04462081 record still lists
NCT04462081 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04462081 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04462081 about?
NCT04462081 is a clinical study titled "Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients". To assess the feasibility in diabetics in a primary care setting of screening for NAFLD and advanced fibrosis, by using non-invasive magnetic resonance imaging (MRI) to estimate the hepatic proton density fat fraction (MRI-PDFF) and magnetic resonance elastography (MRE) to estimate hepatic stiffness...
What is the current status of trial NCT04462081?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-01. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT04462081?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia